Topical ketamine in the treatment of mucositis pain

Pain Medicine

Volumn 4, Issue 3, 2003, Pages 298-303

  Slatkin, Neal E ^a   Rhiner, Michelle ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Head and neck cancer; Ketamine; Mucositis; NMDA antagonists; Radiation therapy

Indexed keywords

AMITRIPTYLINE; CLONAZEPAM; DIPHENHYDRAMINE; FENTANYL; FLUCONAZOLE; HYDROMORPHONE; KETAMINE; LIDOCAINE; MIRTAZAPINE; MYLANTA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; OPIATE; OXYCODONE; PARACETAMOL; ROFECOXIB; SALIVA SUBSTITUTE; SUCRALFATE; RADIOMIX;

ADULT; CANCER RADIOTHERAPY; CASE REPORT; DRUG MECHANISM; EATING; FEMALE; HUMAN; INTRACTABLE PAIN; MOUTH INFLAMMATION; MUCOSA INFLAMMATION; REST; REVIEW; SIDE EFFECT; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA; ARTICLE; MOUTH HYGIENE; PAIN;

ADULT; ANALGESICS; CARCINOMA, SQUAMOUS CELL; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HUMANS; KETAMINE; MUCOUS MEMBRANE; PAIN, INTRACTABLE; PALLIATIVE CARE; RECEPTORS, N-METHYL-D-ASPARTATE; TONGUE NEOPLASMS;

EID: 0242320430     PISSN: 15262375     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4637.2003.03032.x     Document Type: Review

References (51)

1. Raber-Durlacher JE. Current practices for management of oral mucositis in cancer patients. Support Care Cancer 1999;7:71-4.
2. Weissman DE, Janjan N, Byhardt RW. Assessment of pain during head and neck irradiation. J Pain Symptom Manage 1989;4:90-5.
3. Lee JH, Machtay M, Unger LD, Weinstein GS, Weber RS, Chalian AA, Rosenthal DI. Prophylactic gastrostomy tubes in patients undergoing intensive irradiation for cancer of the head and neck. Arch Otolaryngology Head Neck Surg 1998; 124:871-5.
4. Coda BA, O'Sullivan B, Donaldson G, Bohl S, Chapman CR, Shen DD. Comparative efficacy of patient-controlled administration of morphine, hydromorphone, or sufentanil for the treatment of oral mucositis pain following bone marrow transplantation. Pain 1997;72:333-46.
5. Hill HF, Mackie AM, Coda BA, Iverson K, Chapman CR. Patient-controlled analgesic administration. A comparison of steady-state morphine infusions with bolus doses. Cancer 1991;67:873-82.
6. Bellm LA, Epstein JB, Rose-Ped AM, Fu R, Martin PJ, Fuchs HJ. Assessment of various topical oral formulations by bone marrow transplant recipients. Oral Oncol 2001;37:42-9.
7. Plevova P. Prevention and treatment of chemotherapy- and radiotherapy-induced oral mucositis: A review. Oral Oncol 1999;35:453-70.
8. Allison RR, Vongtama V, Vaughan J, Shin KH. Symptomatic acute mucositis can be minimized or prophylaxed by the combination of sucralfate and fluconazole. Cancer Invest 1995;13:16-22.
9. Samaranayake LP, Robertson AG, MacFarlane TW, Hunter IP, MacFarlane G, Soutar DS, Ferguson MM. The effect of chlorhexidine and benzydamine mouthwashes on mucositis induced by therapeutic irradiation. Clin Radiol 1988;39:291-4.
10. Epstein JB, Silverman S Jr, Paggiarino DA, Crockett S, Schubert MM, Senzer NN, Lockhart PB, Gallagher MJ, Peterson DE, Leveque FG. Benzydamine HCl for prophylaxis of radiation-induced oral mucositis: Results from a multicenter, randomized, double-blind, placebo-controlled clinical trial. Cancer 2001;92:875-85.
11. Cerchietti LC, Navigante AH, Bonomi MR, Zaderajko MA, Menendez PR, Pogany CE, Roth BM. Effect of topical morphine for mucositis-associated pain following concomitant chemoradiotherapy for head and neck carcinoma. Cancer 2002;95:2230-6.
12. Clarkson JE, Worthington HV, Eden OB. Prevetion of oral mucositis or oral candidiasis for patients with cancer receiving chemotherapy (excluding head and neck cancer). Cochrane Database Syst Rev 2000;(2):CD000978.
13. Mercadante S, Lodi F, Sapio M, Calligara M, Serretta R. Long-term ketamine subcutaneous continuous infusion in neuropathic cancer pain. J Pain Symptom Manage 1995;10:564-8.
14. Humphries Y, Melson M, Gore D. Superiority of oral ketamine as an analgesic and sedative for wound care procedures in the pediatric patient with burns. J Burn Care Rehabil 1997;18:34-6.
15. Lauretti GR, Lima IC, Reis MP, Prado WA, Pereira NL. Oral ketamine and transdermal nitroglycerin as analgesic adjuvants to oral morphine therapy for cancer pain management. Anesthesiology 1999; 90:1528-33.
16. Pekoe GM, Smith DJ. The involvement of opiate and monoaminergic neuronal systems in the analgesic effects of ketamine. Pain 1982;12:57-73.
17. Meller ST. Ketamine: Relief from chronic pain through actions at the NMDA receptor? Pain 1996;68:435-6.
18. Eide PK, Stubhaug A, Breivik H, Oye I. Reply to S.T. Meller: Ketamine: Relief from chronic pain through actions at the NMDA receptor. Pain 1997;72:289-91.
19. Orser BA, Pennefather PS, MacDonald JF. Multiple mechanisms of ketamine blockade of N-methyl-D-aspartate receptors. Anesthesiology 1997;86: 903-17.
20. Andersen OK, Felsby S, Nicolaisen L, Bjerring P, Jensen TS, Arendt-Nielsen L. The effect of Ketamine on stimulation of primary and secondary hyperalgesic areas induced by capsaicin - a double-blind, placebo-controlled, human experimental study. Pain 1996;66:51-62.
21. Ilkjaer S, Petersen KL, Brennum J, Wernberg M, Dahl JB. Effect of systemic N-methyl-D-aspartate receptor antagonist (ketamine) on primary and secondary hyperalgesia in humans. Br J Anaesth 1996;76:829-34.
22. Warncke T, Stubhaug A, Jorum E. Ketamine, an NMDA receptor antagonist, suppresses spatial and temporal properties of burn-induced secondary hyperalgesia in man: a double-blind, cross-over comparison with morphine and placebo. Pain 1997; 72:99-106.
23. Pedraz JL, Calvo MB, Lanao JM, Muriel C, Santos Lamas J, Dominguez-Gil A. Pharmacokinetics of rectal ketamine in children. Br J Anaesth 1989;63: 671-4.
24. Idvall J, Holasek J, Stenberg P. Rectal ketamine for induction of anaesthesia in children. Anaesthesia 1983;38:60-4.
25. Clements JA, Nimmo WS, Grant IS. Bioavailability, pharmacokinetics, and analgesic activity of ketamine in humans. J Pharm Sci 1982;71:539-42.
26. Warncke T, Jorum E, Stubhaug A. Local treatment with the N-methyl-D-aspartate receptor antagonist ketamine, inhibit development of secondary hyperalgesia in man by a peripheral action. Neurosci Lett 1997;227:1-4.
27. Lawand NB, Willis WM, Westlund KN. Excitatory amino acid receptor involvement in peripheral nociceptive transmission in rats. Eur J Pharmacol 1997;324:169-77.
28. Pedersen JL, Galle TS, Kehlet H. Peripheral analgesic effects of ketamine in acute inflammatory pain. Anesthesiology 1998;89:58-66.
29. Berger A, Henderson M, Nadoolman W, Duffy V, Cooper D, Saberski L, Bartoshuk L. Oral capsaicin provides temporary relief for oral mucositis pain secondary to chemotherapy/radiation therapy. J Pain Symptom Manage 1995;10:243-8.
30. Sawynok J, Reid AR, Esser MJ. Peripheral antinociceptive action of amitriptyline in the rat formalin test: Involvement of adenosine. Pain 1999;80:45-55.
31. Ehrnrooth E, Grau C, Zachariae R, Andersen J. Randomized trial of opioids versus tricyclic antidepressants for radiation-induced mucositis pain in head and neck cancer. Acta Oncol 2001;40:745-50.
32. Lin YC, Sentivany-Collins S. The analgesic response to intravenous lidocaine in the treatment of mucositis pain in children. ASA Abstracts 2000, Abstract 1258.
33. Petersen KL, Rice FL, Suess F, Berro M, Rowbotham MC. Relief of post-herpetic neuralgia by surgical removal of painful skin. Pain 2002; 98:119-26.
34. Brockmeyer DM, Kendig JJ. Selective effects of ketamine on amino acid-mediated pathways in neuronal rat spinal cord. Br J Anaesth 1995;74:79-84.
35. Yamamura T, Harada K, Okamura A, Kemmotsu O. Is the site of action of ketamine anesthesia the N-methyl-D-aspartate receptor? Anesthesiology 1990;72:704-10.
36. Kolesnikov YA, Pasternak GW. Peripheral blockade of topical morphine tolerance by ketamine. Eur J Pharmacol 1999;374:R1-2.
37. Shimoyama N, Shimoyama M, Inturrisi CE, Elliott KJ. Ketamine attenuates and reverses morphine tolerance in rodents. Anesthesiology 1996;85:1357-66.
38. Trujillo KA. Effects of noncompetitive N-methyl-D-aspartate receptor antagonists on opiate tolerance and physical dependence. Neuropsychopharmacology 1995;13:301-7.
39. Kissin I, Bright CA, Bradley EL Jr. The effect of ketamine on opioid-induced acute tolerance: Can it explain reduction of opioid consumption with ketamine-opioid analgesic combinations? Anesth Analg 2000;91:1483-8.
40. Smith DJ, Perrotti JM, Mansell AL, Monroe PJ. Ketamine analgesia is not related to an opiate action in the periaqueductal gray region of the rat brain. Pain 1985;21:253-65.
41. Finck AD, Ngai SH. Opiate receptor mediation of ketamine analgesia. Anesthesiology 1982;56:291-7.
42. Smith DJ, Westfall DP, Adams JD. Assessment of the potential agonistic and antagonistic properties of ketamine at opiate receptors in the guinea-pig ileum. Neuropharmacology 1982;21:605-11.
43. Crain SM, Shen KF. Antagonists of excitatory opioid receptor function enhance morphine's analgesic potency and attenuate opioid tolerance/dependence liability. Pain 2000;84:121-31.
44. Krajnik M, Zylicz Z, Finlay I, Luczak J, van Sorge AA. Potential uses of topical opioids in palliative care-report of 6 cases. Pain 1999;80:121-5.
45. Twillman RK, Long TD, Cathers TA, Mueller DW. Treatment of painful skin ulcers with topical opioids. J Pain Symptom Manage 1999;17:288-92.
46. Benoit E, Carratu MR, Dubois JM, Mitolo-Chieppa D. Mechanism of action of ketamine in the current and voltage clamped myelinated nerve fibre of the frog. Br J Pharmacol 1986;87:291-7.
47. Zhou ZS, Zhao ZQ. Ketamine blockage of both tetrodotoxin (TTX)-sensitive and TTX-resistant sodium channels of rat dorsal root ganglion neurons. Brain Res Bull 2000;52:427-33.
48. Hirota K, Zsigmond EK, Matsuki A, Rabito SF. Topical ketamine inhibits albumin extravasation in chemical peritonitis in rats. Acta Anaesthesiol Scand 1995;39:174-8.
49. Hill GE, Anderson JL, Lyden ER. Ketamine inhibits the proinflammatory cytokine-induced reduction of cardiac intracellular cAMP accumulation. Anesth Analg 1998;87:1015-9.
50. Sonis ST, Peterson RL, Edwards LJ, Lucey CA, Wang L, Mason L, Login G, Ymamkawa M, Moses G, Bouchard P, Hayes LL, Bedrosian C, Dorner AJ. Defining mechanisms of action of interleukin-11 on the progression of radiation-induced oral mucositis in hamsters. Oral Oncol 2000;36:373-81.
51. White SK. The pharmacology of benzydamine. Res Clin Forum 1989;10:9-23.